Mahatme Sandesh 4
4 · Sarepta Therapeutics, Inc. · Filed Feb 28, 2020
Insider Transaction Report
Form 4
Mahatme Sandesh
Senior Vice President, CFO
Transactions
- Award
Common Stock
2020-02-28+6,700→ 36,879 total - Award
Stock option (right to buy)
2020-02-28+37,500→ 37,500 totalExercise: $114.47Exp: 2030-02-28→ Common Stock (37,500 underlying)
Holdings
- 12,012(indirect: By Trust)
Common Stock
Footnotes (2)
- [F1]The Reporting Person was granted restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock. 25% of the shares of common stock underlying each RSU will vest and become exercisable on the first anniversary of the grant date, and additional 25% will vest and become exercisable on each anniversary of the Grant Date thereafter, such that the RSUs will be fully vested and exercisable on the fourth anniversary of the grant date.
- [F2]25% of the option granted vests and is exercisable on the first anniversary of the date of grant and 1/48th of the total granted option will vest and become exercisable on each monthly anniversary thereafter, such that the option will be fully vested and exercisable on the fourth anniversary of the date of grant.